# Daozhi Liu

> Daozhi Liu is a Series B investor at Sunland Fund (Shangai) backing Medical and Biopharma. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sunland Fund](https://shizune.co/investors/profile/sunland-fund)
- Location: Shangai, China
- Total investments: 2
- Last investment: Sep 2021
- Lead investor: 0%
- Last updated: Aug 2026

Daozhi Liu is a Series B investor at Sunland Fund in Shangai focused on Medical and Biopharma. Daozhi Liu is the Founder & Managing Partner of Sunland Fund.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| Biopharma | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

7 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Ennovabio | Ennovabio is a Chinese drug developer that focuses on creating drugs targeting brain glioma. |  | Series B | Sep 26, 2021 |  |
| WuXi Diagnostics | WuXi Diagnostics builds an innovative model that enables diagnostic product innovation, generates clinical insights, and benefits the health of mankind through precision diagnosis and treatment. | $150M | Series B | Feb 23, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [ABC International](https://shizune.co/investors/profile/abc-international) — VC Fund, 1 deal together
- [CCBI Tech Venture](https://shizune.co/investors/profile/ccbi-tech-venture) — VC Fund, 1 deal together
- [Shanghai Biomedical Industrial Equity Investment Fund](https://shizune.co/investors/profile/shanghai-biomedical-industrial-equity-investment-fund) — VC Fund, 1 deal together
- [Shanghai Tiliang Touzi Guanli Youxian Gongsi](https://shizune.co/investors/profile/shanghai-tiliang-touzi-guanli-youxian-gongsi) — VC Fund, 1 deal together
- [Shiyu Capital](https://shizune.co/investors/profile/shiyu-capital) — VC Fund, 1 deal together
- [Thermo Fisher Scientific](https://shizune.co/investors/profile/thermo-fisher-scientific) — VC Fund, 1 deal together

## About Sunland Fund

VC Fund · Shanghai, China

Shanlan Capital is a professional fund focused on early and growing health care industry investments with offices in Shanghai and Beijing, focusing on biomedical and medical devices (in vitro diagnostics and gene technology, minimally invasive interventions, implantable devices, minimally invasive High-growth segments such as surgical instrumentsand medical robots, and medical services. It has invested in 15 medical star companies such as Guoke Hengtai, Ricky Surgery, Jingyi Medical, Haipulos, Langhe Medical, etc. The core team of Shanlan Capital is the founder of the medical industry listed company, professional financial and strategic investment. Composition of people, in strategy formulation, talent introduction, technology research and development, market camp..

2 contacts available at Sunland Fund.

| Name | Title | Profile |
| --- | --- | --- |
| Daozhi Liu | Founder | https://shizune.co/investors/profile/daozhi-liu |
| Gu Shenghan | Executive Director | https://shizune.co/investors/profile/gu-shenghan |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Daozhi Liu invest in?

Daozhi Liu invests primarily in Medical, Biopharma and Health Care startups, most often at Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Daozhi Liu last invest?

The most recent investment recorded for Daozhi Liu closed in Sep 2021. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co